Beyond Seizures: Addressing Neurodevelopment, Quality of Life and Emerging Therapies in Dravet Syndrome Patients - CME - Guideline Central

CME

Title
Beyond Seizures: Addressing Neurodevelopment, Quality of Life and Emerging Therapies in Dravet Syndrome Patients
Link
Description
The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.
Target Audience
This activity was developed for pediatricians, primary care physicians, neurologists and epileptologists, nurse practitioners, nurses, physician associates, pharmacists.
Learning Objectives
  • Summarize key characteristics of Dravet syndrome, its clinical presentation to include signs and symptoms beyond seizures, natural history, burden of disease, and unmet needs.
  • Develop an individualized, comprehensive treatment plan for children and adults with Dravet syndrome, using standard-of-care management strategies to alleviate the disease and treatment burden for patients and caregivers.
  • Outline data surrounding investigational therapies for Dravet syndrome, including their ability to bridge unmet needs for patients with the disease.
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pediatrics, Neurology, Primary Care
Keywords
seizures, Dravet syndrome
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • Annenberg Center for Health Sciences at Eisenhower
Commercial Support
  • UCB Pharma Inc
Activity Expiration Date
April 28, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
Nursing1 Contact HoursANCC - American Nurses Credentialing Center
AAPA Category 1 Credit1 CreditsAAPA- American Academy of Physician Associates
Pharmacy1 Contact HoursACPE- Accreditation Council for Pharmacy Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.